Prospective Biospecimen Collection Services
Prospective Biospecimen
Collection Services
Sanguine prospective biospecimen collection
including blood, stool, urine, and leukopaks
Sanguine's prospective biospecimen collections offer a flexible, on-demand solution tailored to your research needs. Through our direct-to-donor model, we provide fresh, high-quality samples collected at the precise time points you require. Whether you need specific disease-state samples, healthy controls, or longitudinal collections, our expansive donor network covering over 100 diagnosed conditions ensures access to the exact biospecimens you need. With customizable collection protocols and seamless logistics, Sanguine accelerates your research while maintaining the highest standards of quality and compliance. Discover how our prospective collections can elevate your next study.
You define the criteria for your samples, and Sanguine handles everything else.
Ensuring your project can come to fruition is essential and we pride ourselves in if we stay we can do it, we can. How are we so confident in our ability to assess feasibility? First, we tap into our extensive donor network. Sometimes, though, we need to expand our search. One of our avenues is engaging with patient advocacy groups and foundations to connect with potential donors.
Human biospecimens we collect
Our experienced phlebotomy team collects samples in the donor's home or at an apheresis center. We can collect multiple types of samples at a single visit, perform collections for longitudinal studies, and further process samples in-home or send to our lab depending upon your needs.
Blood derived biofluids and products
- Whole blood
- Serum
- Plasma
- Buffy coat
- Peripheral blood mononuclear cells
Non-Blood Derived Biofluids
- Nasal mucosa swabs
- Non-induced sputum
- Saliva
- Semen
- Stool
- Urine
Integumentary
Tissues
- Fingernails
- Hair
- Skin
Apheresis
Products
-
LeukoCore™ RUO leukopaks
-
LeukoLot™ PBMC
-
LeukoCert™ GMP-grade leukopaks
How do we find the biospecimens you need?
The short answer - our Donor Network of 70,000 and growing. We have over 100 verified-diagnosed conditions including rare diseases. With our comprehensive donor data, partnerships with over 100 non-profit and patient advocacy groups, we can find the donors to fit your I/E criteria.
- Donor Access and Engagement
Strategies for reach, recruitment, retention
Geographic and demographic diversity
Diversity of disease states
Donor Centric- Study Design Capabilities
Sample collection
Participant retention
(longitudinal studies)
Donor Data
Post-collection processing- Clinically Relevant Annotated Specimens
Sample integrity
Samples and data collected by Sanguine
Longitudinal sampling
Simultaneous collection of multiple specimen types
Large volume collection (≤180 mL)
Patient-reported outcomes data
(PRO, ePRO)
Same-day sample collection and delivery- Specialty Biospecimen Collection
Leukopaks (leukocyte-enriched apheresis products)
Healthy specimens collected at client’s facilities
Direct Donor Access
Sanguine Model
- Donor Access and Engagement
-
Strategies for reach, recruitment, retention Mobile, virtual, flexible -
Geographic and demographic diversity Nationwide, urban or rural -
Diversity of disease states Broad with over 100 diagnosed conditions -
Donor Centric Engaged homegrown communities - Study Design Capabilities
-
Sample collection Prospective -
Participant retention
(longitudinal studies) High retention rates >95% -
Donor Data FHIR electronic health records, demographics, ability to add surveys, questionnaires, and outcomes -
Post-collection processing Customize parameters and procedures - Clinically Relevant Annotated Specimens
-
Sample integrity 
-
Samples and data collected by Sanguine 
-
Longitudinal sampling
-
Simultaneous collection of multiple specimen types 
-
Large volume collection (≤180 mL) 
-
Patient-reported outcomes data
(PRO, ePRO)
-
Same-day sample collection and delivery 
- Specialty Biospecimen Collection
-
Leukopaks (leukocyte-enriched apheresis products) 
-
Healthy specimens collected at client’s facilities 
Indirect Donor Access
Biobanks and other providers
- Donor Access and Engagement
-
Strategies for reach, recruitment, retention Confined, brick and mortar -
Geographic and demographic diversity Limited by access to medical facility -
Diversity of disease states Typically oncology-focused -
Donor Centric Third-party mediated, transactional - Study Design Capabilities
-
Sample collection Retrospective -
Participant retention
(longitudinal studies) Low or no retention -
Donor Data Often limited to demographics or possibly medical records -
Post-collection processing Limited to how specimens were initially collected - Clinically Relevant Annotated Specimens
-
Sample integrity 
-
Samples and data collected by Sanguine 
-
Longitudinal sampling
-
Simultaneous collection of multiple specimen types 
-
Large volume collection (≤180 mL) 
-
Patient-reported outcomes data
(PRO, ePRO)
-
Same-day sample collection and delivery 
- Specialty Biospecimen Collection
-
Leukopaks (leukocyte-enriched apheresis products) Specialty vendors -
Healthy specimens collected at client’s facilities 
Autoimmune & Inflammatory Diseases
Genetic Diseases
Infectious Diseases
Oncology
Cardiovascular Diseases
Hematologic Diseases
Neurological Diseases
Respiratory and Metabolic Diseases
Related Products and Services
Resources
Brochure
Learn about our portfolio and explore short case studies of Sanguine collections in action.
Blog
Explore the benefits of our direct-to-donor model and learn how our connection can propel your research.
eBook
Discover how translational precision medicine with the right biospecimens is key for advancing medicine.
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.